211 related articles for article (PubMed ID: 15986415)
1. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
Lok AS; Ghany MG; Goodman ZD; Wright EC; Everson GT; Sterling RK; Everhart JE; Lindsay KL; Bonkovsky HL; Di Bisceglie AM; Lee WM; Morgan TR; Dienstag JL; Morishima C
Hepatology; 2005 Aug; 42(2):282-92. PubMed ID: 15986415
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
3. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
4. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
5. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
[TBL] [Abstract][Full Text] [Related]
6. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
7. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
8. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
Imperiale TF; Said AT; Cummings OW; Born LJ
Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a model to diagnose cirrhosis in patients with hepatitis C.
Kaul V; Friedenberg FK; Braitman LE; Anis U; Zaeri N; Fazili J; Herrine SK; Rothstein KD
Am J Gastroenterol; 2002 Oct; 97(10):2623-8. PubMed ID: 12385450
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
[TBL] [Abstract][Full Text] [Related]
11. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
Yu ML; Lin SM; Lee CM; Dai CY; Chang WY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Liaw YF
Hepatology; 2006 Nov; 44(5):1086-97. PubMed ID: 17058238
[TBL] [Abstract][Full Text] [Related]
12. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
Benlloch S; Berenguer M; Prieto M; Rayón JM; Aguilera V; Berenguer J
Liver Transpl; 2005 Apr; 11(4):456-62. PubMed ID: 15776403
[TBL] [Abstract][Full Text] [Related]
13. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
Islam S; Antonsson L; Westin J; Lagging M
Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
[TBL] [Abstract][Full Text] [Related]
14. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
15. King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
Cross TJ; Rizzi P; Berry PA; Bruce M; Portmann B; Harrison PM
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):730-8. PubMed ID: 19430302
[TBL] [Abstract][Full Text] [Related]
16. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.
Hui AY; Chan HL; Wong VW; Liew CT; Chim AM; Chan FK; Sung JJ
Am J Gastroenterol; 2005 Mar; 100(3):616-23. PubMed ID: 15743360
[TBL] [Abstract][Full Text] [Related]
17. Artificial neural network model is superior to logistic regression model in predicting treatment outcomes of interferon-based combination therapy in patients with chronic hepatitis C.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Wu JJ
Intervirology; 2008; 51(1):14-20. PubMed ID: 18309244
[TBL] [Abstract][Full Text] [Related]
18. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
[TBL] [Abstract][Full Text] [Related]
19. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
